Similar articles for PMID: 28467997

Year	Number of Results
2006	2
2011	1
2013	3
2014	4
2015	8
2016	26
2017	28
2018	19
2019	7
2020	4
2021	9
2022	4
2023	1
2024	0

1

Treating Hepatitis C in Patients with Renal Failure.

Lens S, Rodriguez-Tajes S, Llovet LP, Maduell F, Londoño MC. Lens S, et al. Dig Dis. 2017;35(4):339-346. doi: 10.1159/000456585. Epub 2017 May 3. Dig Dis. 2017. PMID: 28467997 Review.

2

Direct-acting antivirals for hepatitis C virus in patients on maintenance dialysis.

Fabrizi F, Donato FM, Messa P. Fabrizi F, et al. Int J Artif Organs. 2017 Oct 13;40(10):531-541. doi: 10.5301/ijao.5000613. Epub 2017 Jul 8. Int J Artif Organs. 2017. PMID: 28708211 Review.

3

[Direct-acting antiviral agents, hepatitis C and dialysis: an update].

Fabrizi F, Lampertico P, Messa P. Fabrizi F, et al. G Ital Nefrol. 2018 Sep;35(5):2018-vol5. G Ital Nefrol. 2018. PMID: 30234230 Free article. Italian.

4

New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.

Fabrizi F, Martin P, Messa P. Fabrizi F, et al. Kidney Int. 2016 May;89(5):988-994. doi: 10.1016/j.kint.2016.01.011. Epub 2016 Mar 11. Kidney Int. 2016. PMID: 27083277 Free article. Review.

5

Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C.

Fernández I, Muñoz-Gómez R, Pascasio JM, Baliellas C, Polanco N, Esforzado N, Arias A, Prieto M, Castells L, Cuervas-Mons V, Hernández O, Crespo J, Calleja JL, Forns X, Londoño MC. Fernández I, et al. J Hepatol. 2017 Apr;66(4):718-723. doi: 10.1016/j.jhep.2016.12.020. Epub 2016 Dec 28. J Hepatol. 2017. PMID: 28039098

6

A review of direct-acting antivirals for the treatment of hepatitis C in patients with advanced chronic kidney disease.

Maruyama A, Partovi N, Yoshida EM, Erb SR, Azalgara VM, Hussaini T. Maruyama A, et al. Nephrol Dial Transplant. 2017 Jan 1;32(1):35-41. doi: 10.1093/ndt/gfv361. Nephrol Dial Transplant. 2017. PMID: 26481484 Review.

7

Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals.

Ko SY, Choe WH. Ko SY, et al. Clin Mol Hepatol. 2018 Dec;24(4):351-357. doi: 10.3350/cmh.2017.0063. Epub 2018 Mar 16. Clin Mol Hepatol. 2018. PMID: 29544240 Free PMC article. Review.

8

Hepatitis C virus infection and chronic kidney disease: Time for reappraisal.

Cacoub P, Desbois AC, Isnard-Bagnis C, Rocatello D, Ferri C. Cacoub P, et al. J Hepatol. 2016 Oct;65(1 Suppl):S82-S94. doi: 10.1016/j.jhep.2016.06.011. J Hepatol. 2016. PMID: 27641990 Review.

9

Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency.

Hundemer GL, Sise ME, Wisocky J, Ufere N, Friedman LS, Corey KE, Chung RT. Hundemer GL, et al. Infect Dis (Lond). 2015;47(12):924-9. doi: 10.3109/23744235.2015.1078908. Epub 2015 Aug 18. Infect Dis (Lond). 2015. PMID: 26365684 Free PMC article.

10

Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.

Atsukawa M, Tsubota A, Toyoda H, Takaguchi K, Kondo C, Okubo T, Hiraoka A, Michitaka K, Fujioka S, Uojima H, Watanabe T, Ikeda H, Asano T, Ishikawa T, Matsumoto Y, Abe H, Kato K, Tsuji K, Ogawa C, Shimada N, Iio E, Mikami S, Tanaka Y, Kumada T, Iwakiri K. Atsukawa M, et al. J Gastroenterol Hepatol. 2019 Feb;34(2):364-369. doi: 10.1111/jgh.14447. Epub 2018 Sep 14. J Gastroenterol Hepatol. 2019. PMID: 30144366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

102 results

Results by year